title: Antibiotics.
authors.affiliation: Kavitha S. Dalal is a critical care pharmacist at Virtua in Marlton, N.J. Mary Barna Bridgeman is a clinical associate professor at Rutgers University Ernest Mario School of Pharmacy in Piscataway, N.J.
authors.forename: Kavitha S
authors.initials: KS
authors.lastname: Dalal
authors.forename: Mary Barna
authors.initials: MB
authors.lastname: Bridgeman
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006020:Glycopeptides / Q000627:therapeutic use; D006801:Humans; D000077427:Lipoglycopeptides; D010755:Organophosphates / Q000627:therapeutic use; D010080:Oxazoles / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D017334:Teicoplanin / Q000031:analogs & derivatives / Q000627:therapeutic use; D014640:Vancomycin / Q000031:analogs & derivatives
chemical_list: D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D000077427:Lipoglycopeptides; D010755:Organophosphates; D010080:Oxazoles; D017334:Teicoplanin; C469289:dalbavancin; C515040:tedizolid phosphate; C100708:oritavancin; D014640:Vancomycin